Abstract:
Bersama abyssinica is widely distributed herb in Africa with varying medicinal uses in different countries.
In Tanzania, the plant is famous for treatment of respiratory diseases including tuberculosis, tonsillitis,
bronchitis, asthma and recently used for treatment Covid-19 symptoms. B. abyssinica is rich in several
groups of active compounds including, phenolic acids, coumarins, avonoids and tannins with potential
pharmacological activities. Due to their broad medicinal uses, the water extract of leaf and stem bark has
been registered as herbal medicine known as ‘Coviba Dawa’ for the treatment of viral and bacterial
respiratory infections.
Objective
The aim of this study was to extract active compounds from B.abyssinica, and analyse them for their
effectiveness against Corona virus (SARS-CoV-2), the Delta variant obtained from Basel University thas is
reported to be highly virulent.
Methods
Bersama abyssinica stembark and leaves were air dried, sequentially extracted in various solvent on
increase of polarity to yield extracts and fractions. The extracts were tested for presence of several
metabolites and antioxidant activity. The most active water extract was analyzed by LC-MS/MC for
identication of active compounds and all extracts were shipped to Basel university for anti SARS-CoV-2
Delta B1screening and antiproliferation assay.
Results
The LC-MS/MS analysis of B. abyssinica water extract reveled the presence of four phenolic compounds
namely; 2,4-di-tert-butylphenol, 4-formyl-2-methoxyphenyl propionate; 7,8-Dihydroxy-4-methylcoumarin
and 2,3, 6-trimethoxyavone. These compounds were revealed to have antioxidant activity and futher
invitro analysis against SARS-CoV-2 Delta B1 revealed the antiviral activity against coronavirus.
Conclusion
This study revealed a wide variety of active metabolites in B. abyssinica water extract with high
antioxidant and antiviral activity which points out at B. abyssinica as a potential source of effective anti
viral agents including anti SARS Cov2. We recommend further pre-clinical and clinical evaluation of B.
abyssinica metabolites as potential antiviral and antibacterial agents.